Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2015.10.29
关于公司使用自有资金购置低危害理工业品的通告
2015.10.29
关于向控股子公司提供委托贷款的通告
2015.10.29
第三届监事会第十三次聚会决议通告
2015.10.20
关于签署《召募资金三方羁系协议》的通告
2015.10.20
关于控股子公司立异药物获得I期临床试验备案的通告
2015.10.14
关于公司使用自有资金购置低危害理工业品的希望通告
2015.10.12
关于新增召募资金专项存储账户的通告
2015.10.12
华英证券有限责任公司关于公司使用部分超募资金对外投资的核查意见
2015.10.12
第三届监事会第十二次聚会决议通告
2015.10.12
关于加入设立工业基金的通告
第一页
上一页
91
92
93
94
95
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】